Multiple Sclerosis Journal-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2164721, encodeId=cfb62164e2136, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：临床诊疗;NMOSD 经验分享：MS和NMOSD这个小专业领域内比较好的杂志，我投的是个综述，审稿人很专业，提了很多具体的修改意见，修了2次。审稿速度也还算凑合。 Submit (12-jul-2023) Major revision (04-aug-2023) Re-submit (21-aug-2023) Minor revision (12-sep-2023) Re-submit (18-sep-2023) Accept (20-oct-2023), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23571996062, createdName=guoruoyi1, createdTime=Tue Oct 24 22:28:43 CST 2023, time=2023-10-24, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1095549, encodeId=57e2109554983, content=什么叫有深度的讨论/如何加深讨论深度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095550, encodeId=b1b01095550ad, content=讨论中第一段一定要撰写文章的总括么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847859, encodeId=dc0384e85968, content=直接被拒，原因不明，建议转投online , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e005414046, createdName=ms8714998894105664, createdTime=Thu Oct 25 09:20:17 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=844427, encodeId=417f84442ef7, content=非常专业！没想到涨分了！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52925414013, createdName=ms9885168513176188, createdTime=Wed Jun 27 14:34:49 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544061, encodeId=697854406152, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833645, encodeId=4840833645ed, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：逻辑不明，表达不清楚，直接秒拒。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ac05413990, createdName=ms1582630781068122, createdTime=Fri Sep 02 11:11:39 CST 2016, time=2016-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=521017, encodeId=350e52101e5a, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投两篇个案了，都是秒拒，原因是没有足够表面，它接收<30%的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=282, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8de91708511, createdName=1de999d8m17(暂无匿称), createdTime=Tue Apr 05 12:04:00 CST 2016, time=2016-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512571, encodeId=41785125e17b, content=审稿速度:1.0 经验分享：投了篇个案，3周后拒了，没有审稿意见，说是稿件太多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=378c1615817, createdName=Raymanms, createdTime=Tue Jun 16 19:06:00 CST 2015, time=2015-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501661, encodeId=d97b5016612e, content=The journal focuses on the aetiology and pathogenesis of demyelinating and inflammatory diseases of the central nervous system and on the application of such studies to scientifically based therapy. The following research areas are of particular interest to the journal: Clinical neurology Myelin chemistry Neuroimaging Pathobiology of the blood/brain barrier Glial pathobiology/myelin repair Pathology Epidemiology Therapeutics Genetics Immunology Virology Psychology Rehabilitation. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Mar 10 14:53:00 CST 2014, time=2014-03-10, status=1, ipAttribution=)]

2023-10-24 guoruoyi1 来自河北省

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：临床诊疗;NMOSD
经验分享：MS和NMOSD这个小专业领域内比较好的杂志，我投的是个综述，审稿人很专业，提了很多具体的修改意见，修了2次。审稿速度也还算凑合。
Submit (12-jul-2023)
Major revision (04-aug-2023)
Re-submit (21-aug-2023)
Minor revision (12-sep-2023)
Re-submit (18-sep-2023)
Accept (20-oct-2023)

25 0

[GetPortalCommentsPageByObjectIdResponse(id=2164721, encodeId=cfb62164e2136, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：临床诊疗;NMOSD 经验分享：MS和NMOSD这个小专业领域内比较好的杂志，我投的是个综述，审稿人很专业，提了很多具体的修改意见，修了2次。审稿速度也还算凑合。 Submit (12-jul-2023) Major revision (04-aug-2023) Re-submit (21-aug-2023) Minor revision (12-sep-2023) Re-submit (18-sep-2023) Accept (20-oct-2023), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23571996062, createdName=guoruoyi1, createdTime=Tue Oct 24 22:28:43 CST 2023, time=2023-10-24, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1095549, encodeId=57e2109554983, content=什么叫有深度的讨论/如何加深讨论深度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095550, encodeId=b1b01095550ad, content=讨论中第一段一定要撰写文章的总括么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847859, encodeId=dc0384e85968, content=直接被拒，原因不明，建议转投online , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e005414046, createdName=ms8714998894105664, createdTime=Thu Oct 25 09:20:17 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=844427, encodeId=417f84442ef7, content=非常专业！没想到涨分了！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52925414013, createdName=ms9885168513176188, createdTime=Wed Jun 27 14:34:49 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544061, encodeId=697854406152, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833645, encodeId=4840833645ed, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：逻辑不明，表达不清楚，直接秒拒。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ac05413990, createdName=ms1582630781068122, createdTime=Fri Sep 02 11:11:39 CST 2016, time=2016-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=521017, encodeId=350e52101e5a, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投两篇个案了，都是秒拒，原因是没有足够表面，它接收<30%的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=282, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8de91708511, createdName=1de999d8m17(暂无匿称), createdTime=Tue Apr 05 12:04:00 CST 2016, time=2016-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512571, encodeId=41785125e17b, content=审稿速度:1.0 经验分享：投了篇个案，3周后拒了，没有审稿意见，说是稿件太多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=378c1615817, createdName=Raymanms, createdTime=Tue Jun 16 19:06:00 CST 2015, time=2015-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501661, encodeId=d97b5016612e, content=The journal focuses on the aetiology and pathogenesis of demyelinating and inflammatory diseases of the central nervous system and on the application of such studies to scientifically based therapy. The following research areas are of particular interest to the journal: Clinical neurology Myelin chemistry Neuroimaging Pathobiology of the blood/brain barrier Glial pathobiology/myelin repair Pathology Epidemiology Therapeutics Genetics Immunology Virology Psychology Rehabilitation. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Mar 10 14:53:00 CST 2014, time=2014-03-10, status=1, ipAttribution=)]

2021-12-28 乌云背后的幸福线

什么叫有深度的讨论/如何加深讨论深度？

54 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2164721, encodeId=cfb62164e2136, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：临床诊疗;NMOSD 经验分享：MS和NMOSD这个小专业领域内比较好的杂志，我投的是个综述，审稿人很专业，提了很多具体的修改意见，修了2次。审稿速度也还算凑合。 Submit (12-jul-2023) Major revision (04-aug-2023) Re-submit (21-aug-2023) Minor revision (12-sep-2023) Re-submit (18-sep-2023) Accept (20-oct-2023), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23571996062, createdName=guoruoyi1, createdTime=Tue Oct 24 22:28:43 CST 2023, time=2023-10-24, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1095549, encodeId=57e2109554983, content=什么叫有深度的讨论/如何加深讨论深度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095550, encodeId=b1b01095550ad, content=讨论中第一段一定要撰写文章的总括么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847859, encodeId=dc0384e85968, content=直接被拒，原因不明，建议转投online , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e005414046, createdName=ms8714998894105664, createdTime=Thu Oct 25 09:20:17 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=844427, encodeId=417f84442ef7, content=非常专业！没想到涨分了！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52925414013, createdName=ms9885168513176188, createdTime=Wed Jun 27 14:34:49 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544061, encodeId=697854406152, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833645, encodeId=4840833645ed, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：逻辑不明，表达不清楚，直接秒拒。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ac05413990, createdName=ms1582630781068122, createdTime=Fri Sep 02 11:11:39 CST 2016, time=2016-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=521017, encodeId=350e52101e5a, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投两篇个案了，都是秒拒，原因是没有足够表面，它接收<30%的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=282, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8de91708511, createdName=1de999d8m17(暂无匿称), createdTime=Tue Apr 05 12:04:00 CST 2016, time=2016-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512571, encodeId=41785125e17b, content=审稿速度:1.0 经验分享：投了篇个案，3周后拒了，没有审稿意见，说是稿件太多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=378c1615817, createdName=Raymanms, createdTime=Tue Jun 16 19:06:00 CST 2015, time=2015-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501661, encodeId=d97b5016612e, content=The journal focuses on the aetiology and pathogenesis of demyelinating and inflammatory diseases of the central nervous system and on the application of such studies to scientifically based therapy. The following research areas are of particular interest to the journal: Clinical neurology Myelin chemistry Neuroimaging Pathobiology of the blood/brain barrier Glial pathobiology/myelin repair Pathology Epidemiology Therapeutics Genetics Immunology Virology Psychology Rehabilitation. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Mar 10 14:53:00 CST 2014, time=2014-03-10, status=1, ipAttribution=)]

2021-12-27 ms6000000264964247

讨论中第一段一定要撰写文章的总括么？

51 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2164721, encodeId=cfb62164e2136, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：临床诊疗;NMOSD 经验分享：MS和NMOSD这个小专业领域内比较好的杂志，我投的是个综述，审稿人很专业，提了很多具体的修改意见，修了2次。审稿速度也还算凑合。 Submit (12-jul-2023) Major revision (04-aug-2023) Re-submit (21-aug-2023) Minor revision (12-sep-2023) Re-submit (18-sep-2023) Accept (20-oct-2023), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23571996062, createdName=guoruoyi1, createdTime=Tue Oct 24 22:28:43 CST 2023, time=2023-10-24, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1095549, encodeId=57e2109554983, content=什么叫有深度的讨论/如何加深讨论深度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095550, encodeId=b1b01095550ad, content=讨论中第一段一定要撰写文章的总括么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847859, encodeId=dc0384e85968, content=直接被拒，原因不明，建议转投online , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e005414046, createdName=ms8714998894105664, createdTime=Thu Oct 25 09:20:17 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=844427, encodeId=417f84442ef7, content=非常专业！没想到涨分了！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52925414013, createdName=ms9885168513176188, createdTime=Wed Jun 27 14:34:49 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544061, encodeId=697854406152, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833645, encodeId=4840833645ed, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：逻辑不明，表达不清楚，直接秒拒。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ac05413990, createdName=ms1582630781068122, createdTime=Fri Sep 02 11:11:39 CST 2016, time=2016-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=521017, encodeId=350e52101e5a, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投两篇个案了，都是秒拒，原因是没有足够表面，它接收<30%的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=282, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8de91708511, createdName=1de999d8m17(暂无匿称), createdTime=Tue Apr 05 12:04:00 CST 2016, time=2016-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512571, encodeId=41785125e17b, content=审稿速度:1.0 经验分享：投了篇个案，3周后拒了，没有审稿意见，说是稿件太多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=378c1615817, createdName=Raymanms, createdTime=Tue Jun 16 19:06:00 CST 2015, time=2015-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501661, encodeId=d97b5016612e, content=The journal focuses on the aetiology and pathogenesis of demyelinating and inflammatory diseases of the central nervous system and on the application of such studies to scientifically based therapy. The following research areas are of particular interest to the journal: Clinical neurology Myelin chemistry Neuroimaging Pathobiology of the blood/brain barrier Glial pathobiology/myelin repair Pathology Epidemiology Therapeutics Genetics Immunology Virology Psychology Rehabilitation. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Mar 10 14:53:00 CST 2014, time=2014-03-10, status=1, ipAttribution=)]

2018-10-25 ms8714998894105664

直接被拒，原因不明，建议转投online

119 0

[GetPortalCommentsPageByObjectIdResponse(id=2164721, encodeId=cfb62164e2136, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：临床诊疗;NMOSD 经验分享：MS和NMOSD这个小专业领域内比较好的杂志，我投的是个综述，审稿人很专业，提了很多具体的修改意见，修了2次。审稿速度也还算凑合。 Submit (12-jul-2023) Major revision (04-aug-2023) Re-submit (21-aug-2023) Minor revision (12-sep-2023) Re-submit (18-sep-2023) Accept (20-oct-2023), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23571996062, createdName=guoruoyi1, createdTime=Tue Oct 24 22:28:43 CST 2023, time=2023-10-24, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1095549, encodeId=57e2109554983, content=什么叫有深度的讨论/如何加深讨论深度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095550, encodeId=b1b01095550ad, content=讨论中第一段一定要撰写文章的总括么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847859, encodeId=dc0384e85968, content=直接被拒，原因不明，建议转投online , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e005414046, createdName=ms8714998894105664, createdTime=Thu Oct 25 09:20:17 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=844427, encodeId=417f84442ef7, content=非常专业！没想到涨分了！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52925414013, createdName=ms9885168513176188, createdTime=Wed Jun 27 14:34:49 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544061, encodeId=697854406152, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833645, encodeId=4840833645ed, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：逻辑不明，表达不清楚，直接秒拒。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ac05413990, createdName=ms1582630781068122, createdTime=Fri Sep 02 11:11:39 CST 2016, time=2016-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=521017, encodeId=350e52101e5a, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投两篇个案了，都是秒拒，原因是没有足够表面，它接收<30%的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=282, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8de91708511, createdName=1de999d8m17(暂无匿称), createdTime=Tue Apr 05 12:04:00 CST 2016, time=2016-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512571, encodeId=41785125e17b, content=审稿速度:1.0 经验分享：投了篇个案，3周后拒了，没有审稿意见，说是稿件太多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=378c1615817, createdName=Raymanms, createdTime=Tue Jun 16 19:06:00 CST 2015, time=2015-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501661, encodeId=d97b5016612e, content=The journal focuses on the aetiology and pathogenesis of demyelinating and inflammatory diseases of the central nervous system and on the application of such studies to scientifically based therapy. The following research areas are of particular interest to the journal: Clinical neurology Myelin chemistry Neuroimaging Pathobiology of the blood/brain barrier Glial pathobiology/myelin repair Pathology Epidemiology Therapeutics Genetics Immunology Virology Psychology Rehabilitation. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Mar 10 14:53:00 CST 2014, time=2014-03-10, status=1, ipAttribution=)]

2018-06-27 ms9885168513176188

非常专业！没想到涨分了！

137 0

[GetPortalCommentsPageByObjectIdResponse(id=2164721, encodeId=cfb62164e2136, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：临床诊疗;NMOSD 经验分享：MS和NMOSD这个小专业领域内比较好的杂志，我投的是个综述，审稿人很专业，提了很多具体的修改意见，修了2次。审稿速度也还算凑合。 Submit (12-jul-2023) Major revision (04-aug-2023) Re-submit (21-aug-2023) Minor revision (12-sep-2023) Re-submit (18-sep-2023) Accept (20-oct-2023), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23571996062, createdName=guoruoyi1, createdTime=Tue Oct 24 22:28:43 CST 2023, time=2023-10-24, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1095549, encodeId=57e2109554983, content=什么叫有深度的讨论/如何加深讨论深度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095550, encodeId=b1b01095550ad, content=讨论中第一段一定要撰写文章的总括么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847859, encodeId=dc0384e85968, content=直接被拒，原因不明，建议转投online , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e005414046, createdName=ms8714998894105664, createdTime=Thu Oct 25 09:20:17 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=844427, encodeId=417f84442ef7, content=非常专业！没想到涨分了！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52925414013, createdName=ms9885168513176188, createdTime=Wed Jun 27 14:34:49 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544061, encodeId=697854406152, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833645, encodeId=4840833645ed, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：逻辑不明，表达不清楚，直接秒拒。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ac05413990, createdName=ms1582630781068122, createdTime=Fri Sep 02 11:11:39 CST 2016, time=2016-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=521017, encodeId=350e52101e5a, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投两篇个案了，都是秒拒，原因是没有足够表面，它接收<30%的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=282, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8de91708511, createdName=1de999d8m17(暂无匿称), createdTime=Tue Apr 05 12:04:00 CST 2016, time=2016-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512571, encodeId=41785125e17b, content=审稿速度:1.0 经验分享：投了篇个案，3周后拒了，没有审稿意见，说是稿件太多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=378c1615817, createdName=Raymanms, createdTime=Tue Jun 16 19:06:00 CST 2015, time=2015-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501661, encodeId=d97b5016612e, content=The journal focuses on the aetiology and pathogenesis of demyelinating and inflammatory diseases of the central nervous system and on the application of such studies to scientifically based therapy. The following research areas are of particular interest to the journal: Clinical neurology Myelin chemistry Neuroimaging Pathobiology of the blood/brain barrier Glial pathobiology/myelin repair Pathology Epidemiology Therapeutics Genetics Immunology Virology Psychology Rehabilitation. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Mar 10 14:53:00 CST 2014, time=2014-03-10, status=1, ipAttribution=)]

2017-07-16 wang_di98

徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了

164 0

[GetPortalCommentsPageByObjectIdResponse(id=2164721, encodeId=cfb62164e2136, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：临床诊疗;NMOSD 经验分享：MS和NMOSD这个小专业领域内比较好的杂志，我投的是个综述，审稿人很专业，提了很多具体的修改意见，修了2次。审稿速度也还算凑合。 Submit (12-jul-2023) Major revision (04-aug-2023) Re-submit (21-aug-2023) Minor revision (12-sep-2023) Re-submit (18-sep-2023) Accept (20-oct-2023), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23571996062, createdName=guoruoyi1, createdTime=Tue Oct 24 22:28:43 CST 2023, time=2023-10-24, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1095549, encodeId=57e2109554983, content=什么叫有深度的讨论/如何加深讨论深度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095550, encodeId=b1b01095550ad, content=讨论中第一段一定要撰写文章的总括么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847859, encodeId=dc0384e85968, content=直接被拒，原因不明，建议转投online , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e005414046, createdName=ms8714998894105664, createdTime=Thu Oct 25 09:20:17 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=844427, encodeId=417f84442ef7, content=非常专业！没想到涨分了！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52925414013, createdName=ms9885168513176188, createdTime=Wed Jun 27 14:34:49 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544061, encodeId=697854406152, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833645, encodeId=4840833645ed, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：逻辑不明，表达不清楚，直接秒拒。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ac05413990, createdName=ms1582630781068122, createdTime=Fri Sep 02 11:11:39 CST 2016, time=2016-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=521017, encodeId=350e52101e5a, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投两篇个案了，都是秒拒，原因是没有足够表面，它接收<30%的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=282, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8de91708511, createdName=1de999d8m17(暂无匿称), createdTime=Tue Apr 05 12:04:00 CST 2016, time=2016-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512571, encodeId=41785125e17b, content=审稿速度:1.0 经验分享：投了篇个案，3周后拒了，没有审稿意见，说是稿件太多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=378c1615817, createdName=Raymanms, createdTime=Tue Jun 16 19:06:00 CST 2015, time=2015-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501661, encodeId=d97b5016612e, content=The journal focuses on the aetiology and pathogenesis of demyelinating and inflammatory diseases of the central nervous system and on the application of such studies to scientifically based therapy. The following research areas are of particular interest to the journal: Clinical neurology Myelin chemistry Neuroimaging Pathobiology of the blood/brain barrier Glial pathobiology/myelin repair Pathology Epidemiology Therapeutics Genetics Immunology Virology Psychology Rehabilitation. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Mar 10 14:53:00 CST 2014, time=2014-03-10, status=1, ipAttribution=)]

2016-09-02 ms1582630781068122

审稿速度:6.0 | 投稿命中率:25.0
经验分享：逻辑不明，表达不清楚，直接秒拒。

133 0

[GetPortalCommentsPageByObjectIdResponse(id=2164721, encodeId=cfb62164e2136, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：临床诊疗;NMOSD 经验分享：MS和NMOSD这个小专业领域内比较好的杂志，我投的是个综述，审稿人很专业，提了很多具体的修改意见，修了2次。审稿速度也还算凑合。 Submit (12-jul-2023) Major revision (04-aug-2023) Re-submit (21-aug-2023) Minor revision (12-sep-2023) Re-submit (18-sep-2023) Accept (20-oct-2023), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23571996062, createdName=guoruoyi1, createdTime=Tue Oct 24 22:28:43 CST 2023, time=2023-10-24, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1095549, encodeId=57e2109554983, content=什么叫有深度的讨论/如何加深讨论深度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095550, encodeId=b1b01095550ad, content=讨论中第一段一定要撰写文章的总括么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847859, encodeId=dc0384e85968, content=直接被拒，原因不明，建议转投online , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e005414046, createdName=ms8714998894105664, createdTime=Thu Oct 25 09:20:17 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=844427, encodeId=417f84442ef7, content=非常专业！没想到涨分了！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52925414013, createdName=ms9885168513176188, createdTime=Wed Jun 27 14:34:49 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544061, encodeId=697854406152, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833645, encodeId=4840833645ed, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：逻辑不明，表达不清楚，直接秒拒。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ac05413990, createdName=ms1582630781068122, createdTime=Fri Sep 02 11:11:39 CST 2016, time=2016-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=521017, encodeId=350e52101e5a, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投两篇个案了，都是秒拒，原因是没有足够表面，它接收<30%的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=282, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8de91708511, createdName=1de999d8m17(暂无匿称), createdTime=Tue Apr 05 12:04:00 CST 2016, time=2016-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512571, encodeId=41785125e17b, content=审稿速度:1.0 经验分享：投了篇个案，3周后拒了，没有审稿意见，说是稿件太多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=378c1615817, createdName=Raymanms, createdTime=Tue Jun 16 19:06:00 CST 2015, time=2015-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501661, encodeId=d97b5016612e, content=The journal focuses on the aetiology and pathogenesis of demyelinating and inflammatory diseases of the central nervous system and on the application of such studies to scientifically based therapy. The following research areas are of particular interest to the journal: Clinical neurology Myelin chemistry Neuroimaging Pathobiology of the blood/brain barrier Glial pathobiology/myelin repair Pathology Epidemiology Therapeutics Genetics Immunology Virology Psychology Rehabilitation. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Mar 10 14:53:00 CST 2014, time=2014-03-10, status=1, ipAttribution=)]

2016-04-05 1de999d8m17(暂无匿称)

审稿速度:1.0 | 投稿命中率:25.0
经验分享：投两篇个案了，都是秒拒，原因是没有足够表面，它接收<30%的文章

282 0

[GetPortalCommentsPageByObjectIdResponse(id=2164721, encodeId=cfb62164e2136, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：临床诊疗;NMOSD 经验分享：MS和NMOSD这个小专业领域内比较好的杂志，我投的是个综述，审稿人很专业，提了很多具体的修改意见，修了2次。审稿速度也还算凑合。 Submit (12-jul-2023) Major revision (04-aug-2023) Re-submit (21-aug-2023) Minor revision (12-sep-2023) Re-submit (18-sep-2023) Accept (20-oct-2023), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23571996062, createdName=guoruoyi1, createdTime=Tue Oct 24 22:28:43 CST 2023, time=2023-10-24, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1095549, encodeId=57e2109554983, content=什么叫有深度的讨论/如何加深讨论深度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095550, encodeId=b1b01095550ad, content=讨论中第一段一定要撰写文章的总括么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847859, encodeId=dc0384e85968, content=直接被拒，原因不明，建议转投online , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e005414046, createdName=ms8714998894105664, createdTime=Thu Oct 25 09:20:17 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=844427, encodeId=417f84442ef7, content=非常专业！没想到涨分了！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52925414013, createdName=ms9885168513176188, createdTime=Wed Jun 27 14:34:49 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544061, encodeId=697854406152, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833645, encodeId=4840833645ed, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：逻辑不明，表达不清楚，直接秒拒。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ac05413990, createdName=ms1582630781068122, createdTime=Fri Sep 02 11:11:39 CST 2016, time=2016-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=521017, encodeId=350e52101e5a, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投两篇个案了，都是秒拒，原因是没有足够表面，它接收<30%的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=282, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8de91708511, createdName=1de999d8m17(暂无匿称), createdTime=Tue Apr 05 12:04:00 CST 2016, time=2016-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512571, encodeId=41785125e17b, content=审稿速度:1.0 经验分享：投了篇个案，3周后拒了，没有审稿意见，说是稿件太多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=378c1615817, createdName=Raymanms, createdTime=Tue Jun 16 19:06:00 CST 2015, time=2015-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501661, encodeId=d97b5016612e, content=The journal focuses on the aetiology and pathogenesis of demyelinating and inflammatory diseases of the central nervous system and on the application of such studies to scientifically based therapy. The following research areas are of particular interest to the journal: Clinical neurology Myelin chemistry Neuroimaging Pathobiology of the blood/brain barrier Glial pathobiology/myelin repair Pathology Epidemiology Therapeutics Genetics Immunology Virology Psychology Rehabilitation. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Mar 10 14:53:00 CST 2014, time=2014-03-10, status=1, ipAttribution=)]

2015-06-16 Raymanms

审稿速度:1.0
经验分享：投了篇个案，3周后拒了，没有审稿意见，说是稿件太多。

355 0

[GetPortalCommentsPageByObjectIdResponse(id=2164721, encodeId=cfb62164e2136, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：临床诊疗;NMOSD 经验分享：MS和NMOSD这个小专业领域内比较好的杂志，我投的是个综述，审稿人很专业，提了很多具体的修改意见，修了2次。审稿速度也还算凑合。 Submit (12-jul-2023) Major revision (04-aug-2023) Re-submit (21-aug-2023) Minor revision (12-sep-2023) Re-submit (18-sep-2023) Accept (20-oct-2023), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23571996062, createdName=guoruoyi1, createdTime=Tue Oct 24 22:28:43 CST 2023, time=2023-10-24, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1095549, encodeId=57e2109554983, content=什么叫有深度的讨论/如何加深讨论深度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095550, encodeId=b1b01095550ad, content=讨论中第一段一定要撰写文章的总括么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847859, encodeId=dc0384e85968, content=直接被拒，原因不明，建议转投online , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e005414046, createdName=ms8714998894105664, createdTime=Thu Oct 25 09:20:17 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=844427, encodeId=417f84442ef7, content=非常专业！没想到涨分了！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52925414013, createdName=ms9885168513176188, createdTime=Wed Jun 27 14:34:49 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544061, encodeId=697854406152, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833645, encodeId=4840833645ed, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：逻辑不明，表达不清楚，直接秒拒。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ac05413990, createdName=ms1582630781068122, createdTime=Fri Sep 02 11:11:39 CST 2016, time=2016-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=521017, encodeId=350e52101e5a, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投两篇个案了，都是秒拒，原因是没有足够表面，它接收<30%的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=282, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8de91708511, createdName=1de999d8m17(暂无匿称), createdTime=Tue Apr 05 12:04:00 CST 2016, time=2016-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512571, encodeId=41785125e17b, content=审稿速度:1.0 经验分享：投了篇个案，3周后拒了，没有审稿意见，说是稿件太多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=378c1615817, createdName=Raymanms, createdTime=Tue Jun 16 19:06:00 CST 2015, time=2015-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501661, encodeId=d97b5016612e, content=The journal focuses on the aetiology and pathogenesis of demyelinating and inflammatory diseases of the central nervous system and on the application of such studies to scientifically based therapy. The following research areas are of particular interest to the journal: Clinical neurology Myelin chemistry Neuroimaging Pathobiology of the blood/brain barrier Glial pathobiology/myelin repair Pathology Epidemiology Therapeutics Genetics Immunology Virology Psychology Rehabilitation. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Mar 10 14:53:00 CST 2014, time=2014-03-10, status=1, ipAttribution=)]

2014-03-10 匿名用户

The journal focuses on the aetiology and pathogenesis of demyelinating and inflammatory diseases of the central nervous system and on the application of such studies to scientifically based therapy. The following research areas are of particular interest to the journal: Clinical neurology Myelin chemistry Neuroimaging Pathobiology of the blood/brain barrier Glial pathobiology/myelin repair Pathology Epidemiology Therapeutics Genetics Immunology Virology Psychology Rehabilitation.

293 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务